Inovio Pharmaceuticals
INO
$11.50
Share price
8.74%
Change (1 day)
1,392.86%
Change (1 year)
Categories
Inovio Pharmaceuticals (INO) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $53.6 M
According to Inovio Pharmaceuticals's latest financial reports the company's total liabilities are $53.6 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Inovio Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $53.6 M | -57.52% |
| 2022-12-31 | $0.12 B | 31.06% |
| 2021-12-31 | $96.27 M | 22.43% |
| 2020-12-31 | $78.63 M | -43.25% |
| 2019-12-31 | $0.13 B | 214.3% |
| 2018-12-31 | $44.08 M | -1.5% |
| 2017-12-31 | $44.75 M | -11.08% |
| 2016-12-31 | $50.32 M | 32.77% |
| 2015-12-31 | $37.9 M | 87.22% |
| 2014-12-31 | $20.24 M | -42.78% |
| 2013-12-31 | $35.38 M | 244.16% |
| 2012-12-31 | $10.28 M | -22.38% |
| 2011-12-31 | $13.24 M | 47.72% |
| 2010-12-31 | $8.96 M | -53.89% |
| 2009-12-31 | $19.44 M | -2.2% |
| 2008-12-31 | $19.88 M | 127.46% |
| 2007-12-31 | $8.74 M | -29.78% |
| 2006-12-31 | $12.44 M | 125.99% |
| 2005-12-31 | $5.5 M | 1.97% |
| 2004-12-31 | $5.4 M | 357.27% |
| 2003-12-31 | $1.18 M | -30.26% |
| 2002-12-31 | $1.69 M | 1.39% |
| 2001-12-31 | $1.67 M | |
| 2001-03-31 | $1.59 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $98.78 B | 184,190.60% | 🇺🇸 USA |
 Novartis NVS | $54.57 B | 101,720.26% | 🇨🇭 Switzerland |
 Pfizer PFE | $137.21 B | 255,883.42% | 🇺🇸 USA |
 Gilead Sciences GILD | $39.37 B | 73,359.53% | 🇺🇸 USA |
 Merck MRK | $69.04 B | 128,700.44% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $58.82 B | 109,643.98% | 🇬🇧 UK |
 Arrowhead Pharmaceuticals
ARWR | $0.45 B | 744.31% | 🇺🇸 USA |